Barnabas Williams
Senior Postdoctoral Research Associate
My research focuses on the discovery and characterisation of monoclonal antibodies (mAbs) targeting blood stage malaria vaccine candidates. I then use these mAbs to design new, more potent vaccine candidates.
I completed my undergraduate degree in Biochemistry, followed by a MRes in Molecular Microbiology at the University of Bath. After my studies, I worked in research and development for a leading gene and cell therapy company in Oxfordshire. I then completed my PhD at The Jenner Institute, funded by the Oxford-MRC Doctoral Training Partnership, where I researched novel blood-stage malaria vaccines based around the RH5 interacting protein (PfRIPR). I am an Associate Fellow of the Higher Education Academy and Retained lecturer in Biochemistry at Pembroke College.
Recent publications
Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR
Preprint
Williams BG. et al, (2025)
Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR
Preprint
Williams BG. et al, (2025)
Evaluating the potential of cross-species neutralization of anti-PfCyRPA and anti-PfRIPR Monoclonal Antibodies.
Preprint
Guerra N. et al, (2025)
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
Journal article
Barrett JR. et al, (2024), Cell, 187, 4964 - 4980.e21
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
Journal article
King LDW. et al, (2024), Cell Rep Med, 5